Artikel mit Open-Access-Mandaten - Cristian BologaWeitere Informationen
Verfügbar: 63
A comprehensive map of molecular drug targets
R Santos, O Ursu, A Gaulton, AP Bento, RS Donadi, CG Bologa, ...
Nature reviews Drug discovery 16 (1), 19-34, 2017
Mandate: US National Institutes of Health, Cancer Research UK, Wellcome Trust
In vivo effects of a GPR30 antagonist
MK Dennis, R Burai, C Ramesh, WK Petrie, SN Alcon, TK Nayak, ...
Nature chemical biology 5 (6), 421-427, 2009
Mandate: US National Institutes of Health
Unexplored therapeutic opportunities in the human genome
TI Oprea, CG Bologa, S Brunak, A Campbell, GN Gan, A Gaulton, ...
Nature reviews Drug discovery 17 (5), 317-332, 2018
Mandate: US National Institutes of Health, European Molecular Biology Laboratory …
How many rare diseases are there?
M Haendel, N Vasilevsky, D Unni, C Bologa, N Harris, H Rehm, ...
Nature reviews drug discovery 19 (2), 77-78, 2020
Mandate: US National Institutes of Health
Drug repurposing from an academic perspective
TI Oprea, JE Bauman, CG Bologa, T Buranda, A Chigaev, BS Edwards, ...
Drug Discovery Today: Therapeutic Strategies 8 (3-4), 61-69, 2011
Mandate: US National Institutes of Health
Identification of a GPER/GPR30 Antagonist with Improved Estrogen Receptor Counterselectivity
MK Dennis, AS Field, R Burai, C Ramesh, WK Petrie, CG Bologa, ...
The Journal of Steroid Biochemistry and Molecular Biology, 2011
Mandate: US National Institutes of Health
DrugCentral: online drug compendium
O Ursu, J Holmes, J Knockel, CG Bologa, JJ Yang, SL Mathias, SJ Nelson, ...
Nucleic acids research, gkw993, 2016
Mandate: US National Institutes of Health
Pharos: collating protein information to shed light on the druggable genome
DT Nguyen, S Mathias, C Bologa, S Brunak, N Fernandez, A Gaulton, ...
Nucleic acids research 45 (D1), D995-D1002, 2017
Mandate: US National Institutes of Health
Modulation of bitter taste perception by a small molecule hTAS2R antagonist
JP Slack, A Brockhoff, C Batram, S Menzel, C Sonnabend, S Born, ...
Current Biology 20 (12), 1104-1109, 2010
Mandate: US National Institutes of Health, Deutsche Forschungsgemeinschaft
Microbial efflux pump inhibition: tactics and strategies
G P Tegos, M Haynes, J Jacob Strouse, M Md T Khan, C G Bologa, ...
Current pharmaceutical design 17 (13), 1291-1302, 2011
Mandate: US National Institutes of Health
DrugCentral 2021 supports drug discovery and repositioning
S Avram, CG Bologa, J Holmes, G Bocci, TB Wilson, DT Nguyen, ...
Nucleic acids research 49 (D1), D1160-D1169, 2021
Mandate: US National Science Foundation, US National Institutes of Health
A crowdsourcing evaluation of the NIH chemical probes
TI Oprea, CG Bologa, S Boyer, RF Curpan, RC Glen, AL Hopkins, ...
Nature chemical biology 5 (7), 441-447, 2009
Mandate: US National Institutes of Health
DrugCentral 2018: an update
O Ursu, J Holmes, CG Bologa, JJ Yang, SL Mathias, V Stathias, ...
Nucleic acids research 47 (D1), D963-D970, 2019
Mandate: US National Institutes of Health
TCRD and Pharos 2021: mining the human proteome for disease biology
TK Sheils, SL Mathias, KJ Kelleher, VB Siramshetty, DT Nguyen, ...
Nucleic Acids Research 49 (D1), D1334-D1346, 2021
Mandate: US National Institutes of Health
Associating drugs, targets and clinical outcomes into an integrated network affords a new platform for computer‐aided drug repurposing
TI Oprea, SK Nielsen, O Ursu, JJ Yang, O Taboureau, SL Mathias, ...
Molecular informatics 30 (2‐3), 100-111, 2011
Mandate: US National Institutes of Health
Badapple: promiscuity patterns from noisy evidence
JJ Yang, O Ursu, CA Lipinski, LA Sklar, TI Oprea, CG Bologa
Journal of cheminformatics 8, 1-14, 2016
Mandate: US National Institutes of Health
Structural Simplification of Bioactive Natural Products with Multicomponent Synthesis. 3. Fused Uracil-Containing Heterocycles as Novel Topoisomerase-Targeting Agents
NM Evdokimov, S Van slambrouck, P Heffeter, L Tu, B Le Calvé, ...
Journal of Medicinal Chemistry 54 (7), 2012-2021, 2011
Mandate: US National Institutes of Health
Drug target ontology to classify and integrate drug discovery data
Y Lin, S Mehta, H Küçük-McGinty, JP Turner, D Vidovic, M Forlin, A Koleti, ...
Journal of biomedical semantics 8, 1-16, 2017
Mandate: US National Institutes of Health
Emerging trends in the discovery of natural product antibacterials
CG Bologa, O Ursu, TI Oprea, CE Melançon III, GP Tegos
Current Opinion in Pharmacology 13 (5), 678-687, 2013
Mandate: US National Institutes of Health
Fluorescent substrates for flow cytometric evaluation of efflux inhibition in ABCB1, ABCC1, and ABCG2 transporters
JJ Strouse, I Ivnitski-Steele, A Waller, SM Young, D Perez, AM Evangelisti, ...
Analytical biochemistry 437 (1), 77-87, 2013
Mandate: US National Institutes of Health
Angaben zur Publikation und Finanzierung werden automatisch von einem Computerprogramm ermittelt